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Occult renal dysfunction: a mortality and morbidity risk factor in
coronary artery bypass grafting surgery
Antonio Miceli, MD,a,b Vito D. Bruno, MD,a Radek Capoun, MD,a Francesco Romeo, MD,b
Gianni D. Angelini, FRCS,a and Massimo Caputo, MDa
Objective: Elevated preoperative serum creatinine is considered an independent risk factor for postoperative
mortality and morbidity in patients undergoing coronary artery bypass grafting. However, the impact of occult
renal dysfunction, defined as an impairment of glomerular filtration rate with normal serum creatinine, is still
unknown. The aim of this study was to analyze the effects of occult renal dysfunction on early outcomes after
coronary artery bypass grafting.
Methods: This was a retrospective, observational, cohort study of prospectively collected data on 9159 consec-
utive patients with normal serum creatinine levels undergoing coronary artery bypass grafting between April
1996 and February 2009. Patients were divided into two groups based on preoperative creatinine clearance es-
timated with the Cockcroft-Gault equation: 5484 patients with a creatinine clearance  60 mL/min and 3675
patients with a creatinine clearance<60 mL/min (occult renal dysfunction group).
Results: Overall in-hospital mortality was 1%. Occult renal dysfunction was associated with a doubling in the
risk of operative mortality (1.4% vs 0.7%; P ¼ .001), postoperative renal dysfunction (5.1% vs 2.5%;
P<.0001), and need for dialysis (0.8% vs 0.4%; P ¼ .014). Moreover, occult renal dysfunction increased
the risk of stroke (1% vs 0.3%; P<.0001), arrhythmia (28.5% vs 21.2%; P<.0001), and hospital stay>7
days (36.45 vs 24.5%; P<.0001). In a multivariable analysis adjusting for preoperative risk factors, occult renal
dysfunction was confirmed to be an independent predictor of mortality (odds ratio, 1.72), postoperative renal
dysfunction (odds ratio, 1.9), dialysis (odds ratio, 1.82), stroke (odds ratio, 2.6) arrhythmia (odds ratio, 1.42),
and hospital stay>7 days (odds ratio, 1.65).
Conclusions:Occult renal dysfunction is an independent risk factor for early mortality and morbidity in patients
undergoing coronary artery bypass grafting. (J Thorac Cardiovasc Surg 2011;141:771-6)
Elevated preoperative serum creatinine (SCr) is considered
an independent risk factor for postoperative mortality
and morbidity in patients undergoing cardiac surgery.1-4
The overall mortality risk for patients with preoperative
SCr> 130 mmol/L (1.5 mg/dL) ranges from 5% to 30%
and the probability of death increases with the increasing
preoperative SCr level.2-6
Serum creatinine is a specific marker of renal dysfunc-
tion; however, because its generation is determined by
age, race, muscle mass, and dietary intake other than filtra-
tion creatinine, it can remain within the normal range when
renal function is significantly impaired.7,8
Estimated creatinine clearance (eCrCl) has been de-
scribed as a more sensitive screening test in predicting renal
reserve and a better predictor of mortality and morbidity
than SCr in cardiac surgery.5,9-11 On the contrary, Cooper
and colleagues12 analyzed 483,914 patients undergoing cor-
onary artery bypass grafting (CABG) and suggested that var-
ious measures of renal function, including SCr, performed
similarly well in models predicting operative mortality.
However, in all these studies, limited information is given
on the risk associated with occult renal dysfunction (ORD).
The National Kidney Foundation defined chronic kidney
disease as glomerular filtration rate (GFR)< 60 mL/min/
1.73 m2 for  3 months, with or without kidney damage,
and that GFR may be derived by eCrCl.13 According to this
definition, the prevalence of chronic renal disease is among
63 million people in the United States, and it is associated
with increased risk of cardiovascular events.13,14 Given the
rising incidence and prevalence of cardiovascular disease
with declining renal function, it is important to understand
the impact of ORD on adverse events in patients
undergoing cardiac surgery.14,15 Therefore, the aim of our
study was to evaluate the effect of ORD, defined as an
impairment of glomerular filtration rate with normal SCr,
on early clinical outcomes in patients undergoing CABG.
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MATERIALS AND METHODS
Patient Selection and Data Definitions
This was a retrospective, observational, cohort study of prospectively
collected data from consecutive patients undergoing CABG at the Bristol
Heart Institute between April 1996 and February 2009. The study was ap-
proved by the clinical audit committee of the University Hospital Bristol
National Health Service Foundation Trust to meet ethical and legal require-
ments and individual consent was waived. The data collection form is en-
tered in a database (Patient Analysis & Tracking System; Dendrite Clinical
Systems, London, UK) and includes 5 sections that are filled in consecu-
tively by anesthetists, surgeons, and intensive care unit, high dependency
unit, and ward nurses.
The normal range for SCr was defined as 30 to 130 mmol/L (0.34-1.47
mg/dL) and these limits represent the 97.5 percentile of the distribution of
SCr levels in healthy male and female volunteers.8 We analyzed data on all
of the patients undergoing isolated CABG with a preoperative SCr  130
mmol/L ( 1.47 mg/dL). Exclusion criteria were patients who had un-
known SCr concentration before surgery (210 patients) and SCr> 130
mmol/L (>1.47 mg/dL; 1480 patients). According to the National Kidney
Foundation,13 preoperative renal dysfunction was defined as GFR<60mg/
mL/1.73 m2, and measurement of GFR was estimated on the basis of the
Cockroft and Gault16 equation as follows:
eCrCl ¼ ð140AgeÞ3Weight½kgð30:85 if womanÞ
723ðScr½mmol=L=88:4Þ
in which 88.4 is a conversion factor to express SCr in mg/dL.
The final sample size was made of 9159 patients who were divided into
two groups based on eCrCl level: 5484 patients with an eCrCl  60 mL/
min (control patients group) and 3675 (40.1%) patients with eCrCl<60
mL/min (ORD group). Baseline characteristics were defined according to
EuroSCORE model.1 The decision to perform off-pump or on-pump
CABG technique was based on individual surgeon preference.
Study End Points
The primary end point was in-hospital mortality, defined as any death oc-
curringwithin 30days ofoperation. Secondary endpointswerepostoperative
renal dysfunction (PRD), need for postoperative dialysis/hemofiltration, ar-
rhythmia, myocardial infarction (MI), stroke, and hospital stay>7 days. A
diagnosis of postoperative MI was based on the presence of Q waves>
0.04ms, and/or a reduction inRwaves>25% in at least twocontiguous leads
onechocardiogram.ThePRDwasdefined asSCr level>200mmol/L, plus an
increase of at least 1.5 times preoperative baseline concentrations. Postoper-
ative arrhythmiawas defined as any presence of supraventricular arrhythmia.
A diagnosis of strokewas made if therewas evidence of new neurologic def-
icit with morphologic substrate confirmed by computer tomography or nu-
clear magnetic resonance imaging.
Anesthetic, Surgical Technique, and Postoperative
Management
Anesthetic and surgical techniques were standardized for all patients
and have been reported previously.17,18 In brief, for patients undergoing
on-pumpCABG, cardiopulmonary bypass was instituted with the use of as-
cending aortic cannulation and two-stage venous cannulation of the right
atrium. The membrane oxygenator was primed with 1000 mL of Hart-
mann’s crystalloid, 500 mL Gelofusine (B Braun Medical Ltd, Emmen-
brucke, Switzerland), 0.5 g/kg mannitol, 7 mL of 10% calcium
gluconate, and 6000 IU heparin. Alpha-stat pH management was used,
and the systemic temperature was kept between 34C and 36C. Myocar-
dial protection was achieved with intermittent hyperkalaemic warm blood
cardioplegia. For off-pump CABG, the Bristol technique was used to ex-
pose the coronaries and provide stabilization to undertake the anastomo-
sis.18 At the end of surgery, patients were transferred to the intensive
care unit and managed according to the unit protocol.17,18
Statistical Analysis
Continuous data were expressed as mean standard deviation, and cat-
egorical data as percentages. The Kolmogorov–Smirnov test was used to
check for normality of data in the two groups before further analysis. Dif-
ferences between ORD and control group were compared using c2 test for
categorical variables, and the Student t test or the Wilcoxon rank sum test,
as appropriate, for continuous variables. To reduce the effect of selection
bias and potential confounding in this observational study, a propensity
score was undertaken.19 The propensity for ORD was determined without
regard of outcomes by the use of a nonparsimoious multiple logistic-
regression analysis. All the variables listed in Table 1 were included in
the analysis. Logistic regression was performed to assess the effect associ-
ated with ORD on each end point after adjusting for potentially confound-
ing variables listed in Table 1 and the propensity score. Results are reported
as percentages and odds ratios (OR) with 95% confidence interval (CI). All
reported P values are two-sided, and P values of less than .05 were consid-
ered to indicate statistical significance. All statistical analysis was per-
formed with SPSS 15.0 (SPSS Inc, Chicago, Ill).
RESULTS
In the study population of 9159 patients with normal SCr
levels, a total of 3675 (40.1%) patients had an eCrCl<60
mL/min and were classified as having ORD (Figure 1). The
mean ( standard deviation) eCrCl was 51.4 (5.8) mL/min
versus 73.3 (11.2) mL/min, in the ORD and control pa-
tients group, respectively. Baseline characteristics of the
study population are shown in Table 1. Patients in the
ORD group were older and more often female; they were
more likely to have a lower angina functional class, greater
prevalence of hypertension, chronic obstructive pulmonary
disease, extracardiac arteriopathy, and previous cardiac op-
erations. Patients with ORD were also more likely to have
a lower ejection fraction and greater prevalence of New
York Heart Association functional class. The prevalence
of the off-pump procedure was similar between the two
groups.
The overall rate of mortality was 1%. Results from uni-
variate and multivariable logistic analysis are reported in
Tables 2 and 3. The ORD was associated with a doubling
in the risk of death (53 patients [1.4%] vs 38 patients
[0.7%]; OR, 2.1; 95% CI, 1.38-3.19; P ¼ .001), PRD
(189 patients [5.1%] vs 138 patients [2.5%]; OR, 2.1;
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
CrCl ¼ creatinine clearance
eCrCl ¼ estimated creatinine clearance
GFR ¼ glomerular filtration rate
ORD ¼ occult renal dysfunction
MI ¼ myocardial infarction
OR ¼ odds ratio
PRD ¼ postoperative renal dysfunction
SCr ¼ serum creatinine
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95% CI, 1.68-2.27; P<.0001), and need for dialysis (30
patients [0.8%] vs 22 patients [0.4%]; OR, 2; 95% CI,
1.18-3.58; P ¼ .014). There was a significant difference
between ORD and the control patients group in the risk of
stroke (35 patients [1%] vs 18 patients [0.3%]; OR, 2.9;
95% CI, 1.65-5.16; P<.0001), arrhythmia (1046 patients
[28.5%] vs 1163 patients [21.2%]; OR, 1.48; 95% CI,
1.34-1.63; P< .0001), and hospital stay> 7 days. After
adjusting for confounding variables listed in Table 1, as
well as propensity score, the ORD remained an important
predictor of mortality (OR, 1.72; 95% CI, 1.12-2.64; C-sta-
tistic, 0.78), PRD (OR, 1.9; 95% CI, 1.53-2.41; C statistic,
0.84), need for dialysis (OR, 1.82; 95% CI,1.01-3.2; C-sta-
tistic, 0.77), stroke (OR, 2.6; 95% CI, 1.47-4.67; C statistic,
0.8), arrhythmia (OR, 1.42; 95% CI, 1.28-1.57; C statistic,
0.81). The ORD was not significantly associated with in-
creased risk of postoperative MI in either univariate or mul-
tivariable analysis. The median length of hospital stay was
6 days (interquartile range, 5 to 8). The rate of hospital
stay>7 days was higher in the ORD group (1337 patients
[36.4%] vs 1344 patients [24.5%]; OR, 1.76; 95% CI,
1.61-1.93; P< .0001) and at multivariable analysis, the
ORD group was confirmed to be a predictor of length of
stay>7 days (OR, 1.65; 95% CI, 1.5-1.81; C statistic,
0.82). When modeled as univariate continuous variable,
a curvilinear relationship was seen between the estimated
probability of death and eCrCl; a similar relationship was
observed between eCrCl and the estimated probability of
PRD (Figure 2).
DISCUSSION
Our study demonstrates that ORD, defined as an impair-
ment of glomerular filtration rate (eCrCl<60mL/min) with
normal SCr level, is a mortality and morbidity risk factor in
patients undergoing CABG. Specifically, we found that
ORD was associated with doubling in the risk of death,
PRD, and dialysis. Moreover, ORD increased the risk of
stroke, arrhythmia, and length of hospital stay> 7 days.
We observed no significant relationship between ORD
and the risk of postoperative MI.
Earlier studies, as well as the most common risk stratifi-
cations, rely on SCr as a screening test for estimating renal
reserve in predicting adverse outcomes in cardiac sur-
gery.1,20-22 The accuracy of SCr as indicator of renal
disease is limited because it depends on several nonrenal
factors, as well as filtration creatinine; therefore SCr levels
may remain within the normal range when renal function
is significantly impaired. The National Kidney Foundation
published clinical guidelines on evaluation, classification,
and risk stratification in chronic renal failure, identifying
the GFR as the best measure of overall kidney function.13
Chronic kidney disease was defined as GFR<60 mL/min/
1.73m2 for more than 3months with or without kidney dam-
age. This cutoff represents loss of half or more of the adult
level of normal kidney function.13 However, because practi-
cal limitations exist in measuring GFR directly, eCrCl was
considered as an alternative measure of renal function that
estimates GFR.7,13,16 An increased risk of postoperative
mortality and morbidity with decreased estimated GFR
TABLE 1. Baseline characteristics of the patients
Variables CrCl<60 mL/min (n ¼ 3675) CrCl>60 mL/min (n ¼ 5484) P value
Age, mean  SD (y) 70.7  6 59.6  8.3 <.0001
Female 1045 (28.4) 742 (13.5) <.0001
eCrCl,mean  SD (mL/min) 51.4  5.8 73.3  11.2 <.0001
CCS 3-4 class 2028 (55.2) 2675 (48.8) <.0001
NYHA III-IV class 1208 (32.9) 1506 (27.5) <.0001
Diabetes 523 (14.2) 825 (15) .296
Hypertension 2525 (68.4) 3443 (62.8) <.0001
COPD 407 (11.1) 519 (9.5) .013
Neurologic disease 47 (1.3) 56 (1) .296
Extracardiac arteriopaty 365 (9.9) 398 (7.3) <.0001
Previous cardiac surgery 118 (3.2) 121 (2.2) .004
Critical preoperative state 62 (1.7) 65 (1.2) .055
Preoperative EF <.0001
Good 2658 (72.3) 4234 (77.2)
Fair 845 (23) 1058 (19.3)
Poor 172 (4.7) 192 (3.5)
Recent MI 1302 (35.4) 1843 (33.6) .076
Emergency 71 (1.9) 96 (1.8) .578
No. grafts performed 2.74  0.79 2.68  0.84 .001
Off-pump surgery 1720 (46.9) 2263 (48.7) .103
Value are express as n ¼ number of patients and (%) unless specified. CCS, Canadian Cardiovascular Society; COPD, chronic obstructive pulmonary disease; eCrCl, estimated
creatinine clearance; EF, ejection fraction; NYHA, New York Heart Association; MI, myocardial infarction; SD, standard deviation.
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has been previously described among patients undergoing
cardiac surgery.9-12 However, only sub-analysis of a few
studies have focused on patients with normal range
SCr levels and reduced renal function.5,11 Wang and
colleagues5 revealed that among 4603 patients with normal
plasma creatinine levels undergoing cardiac surgery, 28%
had an estimated CrCl< 60 mL/min that was associated
with increased risk of mortality, renal failure requiring dial-
ysis, and major morbidity including cardiovascular, respira-
tory, neurologic, and infectious events.5 In Wijeysundera
and colleagues,11 13% of individual with normal SCr
were found to have ORD; in comparison with patients
with normal renal function, patients with ORD experienced
more than 3-fold increased risk of mortality and renal re-
placement therapy.11 Both these studies were focused on
FIGURE 1. Distribution of estimated creatinine clearance among patients in the study.
TABLE 2. Clinical outcomes
Outcomes
CrCl<60 mL/min
(n ¼ 3675)
CrCl>60 mL/min
(n ¼ 5484)
P
value
Mortality 53 (1.4) 38 (0.7) .001
Renal dysfunction 189 (5.1) 138 (2.5) <.0001
Dialysis 30 (0.8) 22 (0.4) .014
MI 99 (2.7) 129 (2.4) .337
Stroke, n (%) 35 (1) 18 (0.3) <.0001
Arrhythmia, n (%) 1046 (28.5) 1163 (21.2) <.0001
Hospital stay
>7 days, n (%)
1337 (36.4) 1344 (24.5) <.0001
Results are expressed as n¼ number of patients and (%). CrCl, Creatinine clearance;
MI, myocardial infarction.
TABLE 3. Observed and adjusted ORs of postoperative adverse
outcomes after CABG, according to presence or absence of occult
renal dysfunction
OR
Outcomes Crude (95% CI) Adjusted* (95% CI)
Mortality 2.1 (1.38-3.19) 1.72 (1.12-2.64)
Renal dysfunction 2.1 (1.68-2.27) 1.9 (1.53-2.41)
Dialysis 2 (1.18-3.58) 1.82 (1.01-3.2)
MI 1.15 (0.88-1.5) 1.1 (0.84-1.44)
Stroke 2.9 (1.65-5.16) 2.6 (1.47-4.67)
Arrhythmia 1.48 (1.34-1.63) 1.42 (1.28-1.57)
Hospital stay
(>7 days)
1.76 (1.61-1.93) 1.65 (1.5-1.81)
CABG, Coronary artery bypass grafting; CI, confidence interval; OR, odds ratio;
MI, myocardial infarct. *Adjusted for baseline characteristics listed in Table 1 and
propensity score.
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a nonselective population of patient with either ischemic or
valvular heart disease, which could be a significant bias in
retrospective studies. Furthermore, the aim of these studies
was to investigate the accuracy of eCrCl in predicting out-
comes in several categories of risk (normal, mild, moderate,
and severe renal dysfunction), including patients with high
SCr creatinine levels. The risk associated with ORDwas in-
vestigated in a rather limited sample size. Our study was
based on a large homogenous group of patients with normal
SCr levels undergoing isolated CABG, confirming the
greater sensitivity of eCrCl in predicting renal dysfunction,
and adverse postoperative outcomes.
Among 9159 patients with normal SCr levels undergoing
CABG, approximately 40% had an eCrCl< 60 mL/min,
suggestive of ORD. This differs from previous reports
that found an incidence of ORD ranging from 6% to
28%.5,11,23 A possible explanation could be the different
definition of normal range for SCr level. We defined SCr
levels normal range between 30 and 130 mmol (0.34-1.47
mg/dL) and these limits represent the 97.5 percentile of
the distribution of SCr levels in healthy male and female
volunteers.8 In the other studies, the normal range for SCr
was defined as<100 mmol/L (1.1 mg/dL).5,11,23
The association between ORD and adverse outcomes in
patients after CABG may have several explanations. In our
study, patients in the ORD group had a higher prevalence
of hypertension, diabetes, recent MI, left ventricular dys-
function, extracardiac arteriopaty, and chronic obstructive
pulmonary disease, which are well-known cardiovascular
risk factors for adverse events in CABG. The presence of
nontraditional risk factors in renal dysfunction, such as ane-
mia, abnormal calcium/phosphatemetabolism, extracellular
fluid volume overload, electrolyte imbalance, oxidative
stress, inflammation, condition promoting coagulation,
and the effects of toxic metabolitis might break up a delicate
homeostasis leading to increased risk of acute renal failure
and atrial fibrillation, which are strongly associated with
mortality.14,24,25 These hypotheses raise the question of
whether ORD is a marker or a risk factor for worse
outcomes after CABG. However, in our study, we
demonstrated that ORD remained a predictor of mortality
and morbidity after multivariable analysis adjusting for
baseline characteristics and propensity score. Furthermore,
we found that the eCrCl formula was very sensitive in
identifying and unmasking a consistent group of patients
considered ‘‘normal’’ from a renal point of view.
Limitations
This study has several limitations. It is based on the ret-
rospective analysis of our large institutional observational
prospectively collected database, and we are unable to ac-
count for the influence of any residual unmeasured factors
that could affect the adverse outcomes. Furthermore, we
do not have the specific details on the intraoperative and
postoperative management of these patients.
Mortality in coronary artery bypass grafting is a very in-
frequent event, and our data reflect this trend. In our study,
the overall mortality in patients with normal creatinine
levels was 1%, but double in patients with ORD. We
strongly believe that this association is not only statistically
significant but also clinically important.
FIGURE 2. Probability of death and postoperative renal dysfunction (PRD) according to preoperative estimated creatinine clearance.
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The Cockcroft-Gault equation was developed to estimate
CrCl rather than GFR; it may overestimate renal function,
especially in the elderly and obese patients as compared
with 24 hours urine collection samples. Finally, we do not
have information regarding the role of nephropathy induced
by contrast medium administered before serum creatinine
was measured.
CONCLUSIONS
Our study shows that ORD, defined as normal creatinine
level with impaired renal function is associated with in-
creased mortality and postoperative morbidity in patients
undergoing CABG. An accurate assessment of renal func-
tion by estimation of creatinine clearance, in addition to se-
rum creatinine might identify higher risk patients and
provide a better risk stratification that can help optimize
therapeutic strategies in these patients.
This study was supported by The British Heart Foundation, the
GarfieldWeston Trust, and the NIHR Bristol Biomedical Research
Unit in Cardiovascular Medicine. We would like to acknowledge
all the medical and nursing staff who has contributed to the data
collection.
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